Co-Diagnostics Operating Cash Flow 2011-2026 | CODX

Annual Operating Cash Flow Co-Diagnostics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-29.1 M	-29.2 M	-22.1 M	6.57 M	41.1 M	28.2 M	-5.53 M	-4.08 M	-3.21 M	-1.31 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
41.1 M	-29.2 M	-1.87 M

Quarterly Operating Cash Flow Co-Diagnostics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-7.85 M	-	-	-8.75 M	-	-	-	-8.49 M	-	-	-	-5.5 M	-	10.6 M	9.46 M	7.81 M	-	36.2 M	24.7 M	12.3 M	-	8.21 M	-348 K	-1.34 M	-	-3.91 M	-2.7 M	-1.37 M	-	-3.12 M	-1.94 M	-969 K	-	-2.22 M	-668 K	-420 K	-	-756 K	-458 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
36.2 M	-8.75 M	2.43 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	-102 M	$ 18.5	1.04 %	$ 569 M	USA
Celcuity CELC	-153 M	$ 92.59	-	$ 4.33 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Castle Biosciences CSTL	64.3 M	$ 21.08	-	$ 611 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-24.2 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	-185 M	$ 130.12	-	$ 16.3 B	USA
CareDx, Inc CDNA	42 M	$ 22.75	-	$ 1.21 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
ICON Public Limited Company ICLR	1.04 B	$ 151.82	-	$ 11.9 B	Irlanda
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
Illumina ILMN	1.08 B	$ 160.03	-	$ 24.8 B	USA
Interpace Biosciences IDXG	5.83 M	$ 1.74	3.57 %	$ 7.7 M	USA
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-9.68 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-460 M	-	0.12 %	$ 80.1 M	China
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	390 M	$ 99.98	-	$ 6.75 B	USA
Charles River Laboratories International CRL	738 M	$ 189.85	-	$ 9.41 B	USA
Medpace Holdings MEDP	713 M	$ 466.79	-	$ 13.5 B	USA
NeoGenomics NEO	5.23 M	$ 11.44	-	$ 1.47 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Mettler-Toledo International MTD	956 M	$ 1 162.79	-0.02 %	$ 24 B	Schweiz
National Research Corporation NRC	26.4 M	$ 19.75	-	$ 442 M	USA
Myriad Genetics MYGN	1.8 M	$ 4.54	-	$ 420 M	USA
Pacific Biosciences of California PACB	-111 M	$ 1.37	-	$ 411 M	USA
Natera NTRA	215 M	$ 222.82	-	$ 30.5 B	USA
Personalis PSNL	-74.9 M	$ 9.75	-	$ 870 M	USA
Senseonics Holdings SENS	-59.1 M	$ 7.43	-	$ 310 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Biomerica BMRA	-3.84 M	$ 2.05	-	$ 4.71 M	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 271.24	-	$ 22.6 B	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 70.06	-	$ 4.19 B	USA
Waters Corporation WAT	653 M	$ 371.15	-	$ 22.1 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 494.07	-	$ 186 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.66	-2.32 %	$ 237 M	Irlanda
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 9.29	-	$ 2.01 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 204.53	0.01 %	$ 22.7 B	USA